Form 4: Roivant Sciences CEO Matthew Gline Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Matthew Gline, CEO of Roivant Sciences, disposed of 10,945 common shares on May 20, 2024, to cover tax withholding obligations related to vested RSUs.
Summary
- On May 20, 2024, Matthew Gline, the CEO of Roivant Sciences Ltd., disposed of 10,945 common shares.
- The transaction was executed to satisfy tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- The shares were disposed of at a price of $11.37 per share.
- Following the transaction, Gline directly owns 1,142,761 common shares of Roivant Sciences Ltd.
Sentiment
Score: 5
Explanation: The document reports a routine transaction (share disposal for tax obligations), so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal for tax purposes and does not indicate a change in the executive's long-term commitment to the company.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of share disposal transaction |
| 05/22/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.